4.53
[]. Almad A, et al. The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice. Exp Neurol. 0 Dec;3():309-7.
[]. Pahan K, et al. Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J Biol Chem. 00 Nov 9;77(48):45984-9. Epub 00 Sep 8.
[3]. Wang JS, et al. Gemfibrozil inhibits CYPC8-mediated cerivastatin metabolism in human liver microsomes. Drug Metab Dispos. 00 Dec;30():35-.
[4]. Anna Vildhede, et al. Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions. Drug Metab Dispos. 04 Jul;4(7):0-8.
[5]. Daryl N Bulloch, et al. Analytical and biological characterization of halogenated gemfibrozil produced through chlorination of wastewater. Environ Sci Technol. 0 May 5;4(0):5583-9.
H30
P4-P70-P330-P50